Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 149

    1.

    Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide.

    Jonas JB, Bleyl U.

    Br J Ophthalmol. 2004 Jun;88(6):839-40. No abstract available. PMID: 15148228 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration]

    Leparmentier A, Arnaud C, Fournie P, Mathis A, Quintyn JC.

    J Fr Ophtalmol. 2007 Feb;30(2):155-60. French. Erratum in: J Fr Ophtalmol. 2007 Mar;30(3):231. Audrey, L [corrected to Leparmentier, A]. PMID: 17318098 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cataract surgery combined with intravitreal injection of triamcinolone acetonide.

    Jonas JB, Kreissig I, Budde WM, Degenring RF.

    Eur J Ophthalmol. 2005 May-Jun;15(3):329-35.PMID: 15945000 [PubMed - indexed for MEDLINE]Related articles

    4.

    The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration.

    Roth DB, Kulkarni KM, Feuer WJ.

    Ophthalmic Surg Lasers Imaging. 2008 Jan-Feb;39(1):12-6.PMID: 18254345 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.

    Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U, Kamppeter BA.

    Am J Ophthalmol. 2005 Jun;139(6):1073-9.PMID: 15953439 [PubMed - indexed for MEDLINE]Related articles

    6.

    Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.

    Jonas JB, Akkoyun I, Kreissig I, Degenring RF.

    Br J Ophthalmol. 2005 Mar;89(3):321-6.PMID: 15722313 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.

    Jonas JB.

    Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. Review.PMID: 16396641 [PubMed - indexed for MEDLINE]Related articles

    9.

    Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.

    Spandau UH, Derse M, Schmitz-Valckenberg P, Papoulis C, Jonas JB.

    Br J Ophthalmol. 2005 Aug;89(8):999-1003.PMID: 16024853 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.

    Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.

    Am J Ophthalmol. 2006 Jul;142(1):10-16.PMID: 16815246 [PubMed - indexed for MEDLINE]Related articles

    12.

    Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

    Jonas JB, Kreissig I, Degenring RF.

    Br J Ophthalmol. 2004 Dec;88(12):1557-62.PMID: 15548812 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Serum levels of triamcinolone acetonide after intravitreal injection.

    Degenring RF, Jonas JB.

    Am J Ophthalmol. 2004 Jun;137(6):1142-3.PMID: 15183810 [PubMed - indexed for MEDLINE]Related articles

    15.

    Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.

    Arevalo JF, Garcia RA, Mendoza AJ.

    Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1180-5. Epub 2005 May 20.PMID: 15906068 [PubMed - indexed for MEDLINE]Related articles

    16.

    Evaluation of subretinal triamcinolone acetonide in patients with exudative age-related macular degeneration.

    Kozak I, Cheng L, Falkenstein I, Tammewar AM, Freeman WR.

    J Ocul Pharmacol Ther. 2007 Feb;23(1):46-53.PMID: 17341150 [PubMed - indexed for MEDLINE]Related articles

    17.

    Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degeneration.

    Jonas JB, Strueven V, Kamppeter BA, Harder B, Spandau UH, Schlichtenbrede F.

    J Ocul Pharmacol Ther. 2006 Oct;22(5):370-6.PMID: 17076632 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal triamcinolone acetonide for refractory diabetic macular oedema.

    Fernando AI, Pandit JC.

    J R Soc Med. 2005 Sep;98(9):421-2. No abstract available. PMID: 16140858 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization.

    Tatar O, Shinoda K, Kaiserling E, Pertile G, Eckardt C, Mohr A, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.

    Arch Ophthalmol. 2008 Feb;126(2):193-9.PMID: 18268209 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Am J Ophthalmol. 2006 Apr;141(4):638-45.PMID: 16564797 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data